Showing 21-30 of 2067 results for "".
Why Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.Meaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivJulie Harper, MD, Reacts to New Report on Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/julie-harper-md-reacts-new-report-acne-products-benzoyl-peroxide-bpo/24172/In this video, Julie Harper, MD, a dermatologist with the Dermatology and Skin Care Center of Birmingham, AL, provides her thoughts on the recent Valisure report showing that some common acne products with benzoyl peroxide (BPO) may contain benzene. She says she’s been an “avid prescriber” of acne pAesthetics Update: A Q&A With Modern Aesthetics® editors Saami Khalifian, MD, and Kay Durairaj, MD, FACS
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetics-update-a-qa-with-modern-aesthetics-editors-saami-khalifian-md-and-kay-durairaj-md-facs/29203/The world of aesthetic medicine is rapidly evolving, from next-generation polynucleotides and biostimulators to shifts in patient demands and perceptions of beauty. To discuss the latest trends in aesthetics, Practical Dermatology® turned to its sister publication, Modern Aesthetics®, and new ChiefDiane Thiboutot, MD
https://practicaldermatology.com/topics/general-topics/diane-thiboutot-md/21522/Neal Bhatia, MD
https://practicaldermatology.com/topics/practice-management/neal-bhatia-md/22950/Dr. Neal Bhatia is an Associate Professor of Dermatology at Harbor UCLA and is also in private practice in Long Beach, CA. He has published articles on a wide range of topics covering both medical and cosmetic dermatology, and he completed a oneyear appointment on the AAD Board of Directors. Ahead,Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uEmerging Vitiligo Therapies
https://practicaldermatology.com/conferences/maui-derm-2022/emerging-vitiligo-therapies/20047/It’s really an exciting time to be treating vitiligo, says John E. Harris, MD, PhD. He reviews Phase 2 and 3 clinical trials for ruxolitinib, a topical JAK inhibitor, and the hope that the FDA could soon approve it for the treatment of vitiligo. He also discusses other possible targeted treatments iChanging Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysisSkin of Color Session: Dr. Harris
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/skin-of-color-session-dr-harris/32683/John E. Harris, MD, PhD, summarizes his vitiligo talk from the "Skin of Color Session" at Maui Derm 2025, during which he covered new therapeutic options for vitiligo as well as promising drugs in the pipeline and why they could be so impactful.